Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/24045
Title: AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia
Authors: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Genetik Anabilim Dalı.
Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik Hematoloji Anabilim Dalı.
Gülten, Tuna
Yakut, Tahsin
Karkucak, Mutlu
Baytan, Birol
Güneş, Adalet Meral
6505944216
6602802424
35388323500
6506622162
24072843300
Keywords: 17q25
Aberration
Acute lymphoblastic leukemia
AML1 amplification
SEPT9
Abnormalities
Genes
Medical laboratory technology
Issue Date: 2009
Publisher: Wiley
Citation: Gülten, T. vd. (2009). "AML1 amplification and 17q25 deletion in a case of childhood acute lymphoblastic leukemia". Journal of Clinical Laboratory Analysis, 23(6), 368-371.
Abstract: We report a case of childhood acute lymphoblastic leukemia (ALL) with both acute myeloid leukemia 1 (AML1) amplification and 17q25 deletion. AML1 gene is located on 21q22 and encodes a transcription factor. AML1 amplification is a common finding in childhood ALL, and itis observed as an increase in gene copy number by the FISH analysis. The mechanism of AML1 amplification is not associated with AML1 gene mutations. The 17q25 is a gene-rich chromosomal location and distinct abnormalities of this region have been observed in previous cases of different kinds of leukemia. Deletion of the 17q25 region has been reported in two leukemia patients. Septin 9 (SEPT9) and survivin genes are located on 17q25. High expression of these genes and AML1 amplification are regarded as markers in tumorigenesis and disease progression; however, more data are needed for accurate prognostic evaluation.
URI: https://doi.org/10.1002/jcla.20343
https://onlinelibrary.wiley.com/doi/10.1002/jcla.20343
http://hdl.handle.net/11452/24045
ISSN: 0887-8013
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Gülten_vd_2009.pdf103.37 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons